General Psychiatry
RSS
In Brief: Lamotrigine Gets a New Warning
Chris Aiken, MD, and Sarah Rivelli, MD.
Dr. Aiken and Dr. Rivelli have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Read More
A Review of Medications for PTSD, With a Focus on Topiramate
Paul Riordan, MD.
Assistant Consulting Professor of Psychiatry, Duke University.
Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Read More
What’s Wrong With Generics?
Katherine Eban
Katherine Eban is an investigative journalist whose 2019 book Bottle of Lies: The Inside Story of the Generic Drug Boom uncovered problems in generic drug manufacturing. Ms. Eban has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
CLINICAL UPDATE
Depression, Vitamin D, and COVID-19
Paul Riordan, MD.
Assistant Consulting Professor of Psychiatry, Duke University.
Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Read More
Maintenance Pharmacotherapy of Bipolar Disorder: How Long Is Long Enough?
Nicholas Rosenlicht, MD.
Dr. Rosenlicht has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
